PCL Supplements
A Guide to Monitoring and Achieving Asthma Control in Children Younger Than 5 Years
September 2009
Respiratory Syncytial Virus: From Pathogenesis to Prevention
December 2008
Special Issue: Focus on Vaccines
September 2008
FDA issues second CRL for dasiglucagon to treat hypoglycemia in congenital hyperinsulinism
Published: October 8th 2024 | Updated: October 8th 2024This decision marks the second time the FDA has issued a complete response letter (CRL) for dasiglucagon to treat hypoglycemia in patients 7 days and up with congenital hyperinsulinism.